Thursday, June 27, 2019

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharma gets USFDA nod for cholesterol lowering drug The approval has been granted by the the United States Food and Drug Administration (USFDA) for for Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, the company said in a statement.

from Moneycontrol Business News https://ift.tt/2LxxzZV

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...